| Recruiting | A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < Bowel Cleansing Prior to Clinical Procedures | Phase 3 | 2025-12-29 |
| Completed | Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia Colon Cancer, Colon Disease, Colon Cleansing | — | 2021-10-01 |
| Completed | A Pharmacokinetic Study of PLENVU® in Healthy Subjects Pharmacokinetic | Phase 1 | 2020-09-03 |
| Completed | Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) Hepatic Encephalopathy | — | 2015-06-01 |
| Completed | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Toler Colorectal Cancer, Colorectal Carcinoma, Colon Cleansing | Phase 3 | 2014-11-01 |
| Completed | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Toler Colorectal Cancer, Colorectal Carcinoma, Colon Cleansing | Phase 3 | 2014-10-01 |
| Completed | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Toler Colon Cancer, Colorectal Carcinoma, Colon Cleansing | Phase 3 | 2014-09-01 |
| Completed | A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compa Colonoscopy | Phase 1 | 2012-10-01 |
| Completed | Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solut Colon Cancer | Phase 2 | 2012-10-01 |
| Completed | A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Faecal Incontinence | Phase 2 | 2012-02-01 |
| Completed | A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP- Postoperative Ileus | Phase 1 | 2012-02-01 |
| Completed | Evaluation of the Main Determinants of Patient Acceptability of the Bowel Cleansing Procedure, and of Success Routine Colonoscopy | — | 2012-02-01 |
| Completed | Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection Postoperative Ileus | Phase 3 | 2012-02-01 |
| Completed | Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing Colorectal Cancer | N/A | 2011-11-01 |
| Completed | A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Colorectal Cancer | Phase 4 | 2011-11-01 |
| Completed | Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects Digestive System Disorders | Phase 1 | 2011-06-01 |
| Completed | Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers Digestive System Disorders | Phase 1 | 2011-06-01 |
| Completed | Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based G Colorectal Cancer | Phase 1 | 2011-04-01 |
| Completed | Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Re Gastroesophageal Reflux | Phase 3 | 2011-04-01 |
| Completed | Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation Constipation | Phase 3 | 2010-11-01 |
| Completed | A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20m Acid Reflux, Gastro Oesophageal Reflux Disease | Phase 1 | 2010-10-01 |
| Completed | Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence Fecal Incontinence | Phase 1 | 2010-08-01 |
| Completed | Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects Cirrhosis | Phase 1 | 2010-07-01 |
| Completed | Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in E Fecal Incontinence | Phase 1 | 2010-04-01 |
| Completed | Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Supposito Fecal Incontinence | Phase 1 | 2010-03-01 |
| Completed | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cl Colon Cancer | Phase 2 | 2010-03-01 |
| Completed | Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis Hepatic Cirrhosis | Phase 1 | 2009-04-01 |
| Completed | Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972. Hepatitis, Viral, Human | Phase 2 | 2009-03-01 |
| Completed | Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001. Fecal Incontinence | Phase 1 | 2009-02-01 |
| Completed | Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights Incontinence | Phase 1 | 2009-02-01 |
| Completed | Constipation Associated With Irritable Bowel Syndrome (IBS-C) Constipation | Phase 3 | 2008-11-01 |
| Completed | PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | 2008-06-01 |
| Completed | Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Dise Hepatic Cirrhosis | Phase 3 | 2008-03-01 |
| Completed | Effects of Oral PEG 3350 on Electrolyte Balance Chronic Constipation | Phase 1 | 2008-01-01 |
| Completed | Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days Faecal Incontinence | Phase 1 | 2007-08-01 |
| Completed | A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Prepa Gastrointestinal Diseases | Phase 4 | 2007-05-01 |
| Completed | Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum Fecal Incontinence | Phase 1 | 2007-04-01 |
| Completed | Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers Fecal Incontinence | Phase 1 | 2007-04-01 |
| Completed | Scintigraphic Assessment Following Klean-Prep® or Moviprep® Gastric Emptying, Healthy | Phase 1 | 2006-09-01 |
| Completed | Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine Pharmacokinetics | Phase 1 | 2006-06-01 |
| Completed | Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin Hepatic Cirrhosis | Phase 1 | 2006-06-01 |
| Completed | Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers Hepatic Cirrhosis | Phase 1 | 2006-03-01 |
| Completed | MOVIPREP® Versus PICOLAX® Pilot Study Colonoscopy | Phase 2 | 2005-07-01 |
| Completed | Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screeni Colonoscopy | Phase 3 | 2004-09-01 |
| Completed | Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers Hepatic Cirrhosis, Nonalcoholic Steatohepatitis | Phase 1 / Phase 2 | 2004-08-01 |
| Completed | The Safety and Dose Response to Single Anal Doses of NRL001 Faecal Incontinence | Phase 1 | 2002-12-01 |
| Completed | A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Sol Colonoscopy | Phase 3 | 2002-06-01 |
| Completed | MOVIPREP® Versus NaP Pivotal Phase III Study Colonoscopy | Phase 3 | 2002-04-01 |
| Completed | Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children Chronic Constipation | Phase 3 | 2002-04-01 |
| Completed | An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children Chronic Constipation | Phase 3 | 2001-08-01 |
| Completed | A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution Colorectal Cancer | Phase 2 | 2001-05-01 |
| Completed | Clinical Evaluation of a New Reduced Volume Bowel Preparation Colonoscopy | Phase 2 | 2001-01-01 |
| Completed | Movicol in Childhood Constipation (ProMotion Study) Feces, Impacted | Phase 2 | 2000-10-01 |
| Completed | Movicol in Childhood Constipation (ProMotion Study) Chronic Constipation | Phase 2 | 2000-10-01 |